RAPPER — A Success Story for Collaborative Translational Radiotherapy Research-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

RAPPER — A Success Story for Collaborative Translational Radiotherapy Research

Published:2019-07 Issue:7 Volume:31 Page:416-419
ISSN:0936-6555
Container-title:Clinical Oncology
language:en
Short-container-title:Clinical Oncology

Author:

Burnet N.G.,Barnett G.C.,Summersgill H.R.,Dunning A.M.,West C.M.L.

Funder

Cancer Research UK

Manchester Biomedical Research Centre

National Institute for Health Research

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference19 articles.

1. Radiosensitivity, radiogenomics and RAPPER;Burnet;Clin Oncol,2006

2. A randomised controlled trial of forward-planned radiotherapy (IMRT) for early breast cancer: baseline characteristics and dosimetry results;Barnett;Radiother Oncol,2009

3. Establishment of a Radiogenomics Consortium;West;Int J Radiat Oncol Biol Phys,2010

4. Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study;Barnett;Lancet Oncol,2012

5. Standardized Total Average Toxicity score: a scale- and grade-independent measure of late radiotherapy toxicity to facilitate pooling of data from different studies;Barnett;Int J Radiat Oncol Biol Phys,2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Race and Ethnicity on Risk of Radiotherapy Toxicity and Implications for Radiogenomics;Clinical Oncology;2022-10

2. Radiotherapy biobanking: current landscape, opportunities, challenges, and future aspirations;The Journal of Pathology: Clinical Research;2021-10-17

3. Breast cancer radiotherapy: What physicians need to know in the era of the precision medicine;Breast Disease;2021-04-26

4. Predictors of radiation-induced complications in radiation oncology based on cell survival tests after ex vivo exposure: literature review;Український радіологічний та онкологічний журнал;2021-03-29

5. Biobanking in radiotherapy trials — a challenge to the clinical research community;Nature Reviews Clinical Oncology;2021-02-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3